ES2326091T3 - Composicion de aceite de pescado marino antivirica e inmunoestimulante. - Google Patents

Composicion de aceite de pescado marino antivirica e inmunoestimulante. Download PDF

Info

Publication number
ES2326091T3
ES2326091T3 ES05808584T ES05808584T ES2326091T3 ES 2326091 T3 ES2326091 T3 ES 2326091T3 ES 05808584 T ES05808584 T ES 05808584T ES 05808584 T ES05808584 T ES 05808584T ES 2326091 T3 ES2326091 T3 ES 2326091T3
Authority
ES
Spain
Prior art keywords
mass
acid
selenium
ester
sin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05808584T
Other languages
English (en)
Spanish (es)
Inventor
Jeno Szilbereky
Andrea Jednakovits
Ernone Koltai
Gyula Orban
Katalin Biro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SINNEX MUSZAKI FEJLESZTO ES TA
SINNEX MUSZAKI FEJLESZTO ES TANACSADO KFT
Original Assignee
SINNEX MUSZAKI FEJLESZTO ES TA
SINNEX MUSZAKI FEJLESZTO ES TANACSADO KFT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SINNEX MUSZAKI FEJLESZTO ES TA, SINNEX MUSZAKI FEJLESZTO ES TANACSADO KFT filed Critical SINNEX MUSZAKI FEJLESZTO ES TA
Application granted granted Critical
Publication of ES2326091T3 publication Critical patent/ES2326091T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES05808584T 2004-12-03 2005-11-15 Composicion de aceite de pescado marino antivirica e inmunoestimulante. Expired - Lifetime ES2326091T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0402490A HU227588B1 (hu) 2004-12-03 2004-12-03 Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
HU0402490 2004-12-03

Publications (1)

Publication Number Publication Date
ES2326091T3 true ES2326091T3 (es) 2009-09-30

Family

ID=89985663

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05808584T Expired - Lifetime ES2326091T3 (es) 2004-12-03 2005-11-15 Composicion de aceite de pescado marino antivirica e inmunoestimulante.

Country Status (13)

Country Link
US (1) US9381213B2 (enExample)
EP (1) EP1830861B1 (enExample)
JP (1) JP4976307B2 (enExample)
KR (1) KR101263963B1 (enExample)
CN (1) CN101068540B (enExample)
AT (1) ATE429236T1 (enExample)
CA (1) CA2588195C (enExample)
DE (1) DE602005014142D1 (enExample)
DK (1) DK1830861T3 (enExample)
ES (1) ES2326091T3 (enExample)
HU (1) HU227588B1 (enExample)
PL (1) PL1830861T3 (enExample)
WO (1) WO2006059169A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1800675T4 (pl) 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
SMT201800047T1 (it) * 2009-04-29 2018-03-08 Amarin Pharmaceuticals Ie Ltd Composizione farmaceutica stabile e metodi di utilizzo della stessa
JP5710150B2 (ja) * 2010-04-08 2015-04-30 持田製薬株式会社 潜伏性感染疾患の再発抑制剤
JP2012149000A (ja) * 2011-01-18 2012-08-09 Junsei Educational Institution 免疫賦活剤ならびにこれを含む食品および医薬組成物
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
US20220175850A1 (en) * 2019-04-01 2022-06-09 Houn Simon Hsia Compositions and methods for cancer therapy
US11872252B2 (en) * 2020-08-10 2024-01-16 Houn Simon Hsia Compositions and methods for treating viral infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209973B (en) 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
HU199775B (en) 1988-03-09 1990-03-28 Nagy Peter Literati Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
EP0891771A1 (en) * 1997-07-08 1999-01-20 Health Now, Inc. Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases
CA2313024C (en) * 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
AT412758B (de) * 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
EP1487431B1 (en) * 2002-03-08 2012-05-02 PhilERA New Zealand Limited Preventing and/or treating cardiovascular disease and/or associated heart failure

Also Published As

Publication number Publication date
KR20070086689A (ko) 2007-08-27
US20080131519A1 (en) 2008-06-05
EP1830861A2 (en) 2007-09-12
CN101068540B (zh) 2013-01-09
DE602005014142D1 (de) 2009-06-04
JP2008521877A (ja) 2008-06-26
CN101068540A (zh) 2007-11-07
EP1830861B1 (en) 2009-04-22
PL1830861T3 (pl) 2009-09-30
HU0402490D0 (en) 2005-02-28
HUP0402490A2 (en) 2009-04-28
WO2006059169A3 (en) 2007-02-22
DK1830861T3 (da) 2009-07-27
KR101263963B1 (ko) 2013-05-13
ATE429236T1 (de) 2009-05-15
CA2588195A1 (en) 2006-06-08
CA2588195C (en) 2014-12-23
JP4976307B2 (ja) 2012-07-18
WO2006059169A2 (en) 2006-06-08
HU227588B1 (hu) 2011-09-28
US9381213B2 (en) 2016-07-05

Similar Documents

Publication Publication Date Title
US6255347B1 (en) Methods and compositions comprising R-ibuprofen
Isaacs et al. Antiviral and antibacterial lipids in human milk and infant formula feeds.
US9555063B2 (en) Pluripotent therapeutic compositions and uses thereof
KR970006154B1 (ko) 용해성 펩티드에 의한 진핵 병원체와 신생물의 억제 및 섬유아세포와 임파구의 자극
ES2904555T3 (es) Materiales y métodos para mejorar las respuestas inmunitarias y la función de la piel y/o la barrera mucosa
ES3013745T3 (en) Methods and compositions for modulating the immune system with arginase i
CN1200036A (zh) 含有磷脂混合物并具有抗细胞程序死亡活性的组合物
ES2379355T3 (es) Composiciones basadas en aminoácidos para tratamiento de estados patológicos caracterizados por una función mitocondrial insuficiente
WO1997048391A9 (en) Methods and compositions comprising r-ibuprofen
RU2744573C2 (ru) Куркумин-пептидные конъюгаты и их композиции
CA1334576C (en) Antiviral pharmaceutical compositions and process for preparing same
WO2010004060A1 (es) Uso de la cilastatina para reducir la nefrotoxicidad de distintos compuestos
ES2326091T3 (es) Composicion de aceite de pescado marino antivirica e inmunoestimulante.
JPH11501634A (ja) 免疫系異常治療用の胆汁からの免疫調節組成物
ES2423705T3 (es) Péptidos de caseína para su uso como agentes en patologías hepáticas
JP2023541403A (ja) ビオチンをミトコンドリアに送達するための方法及び組成物
ES2171439T5 (es) Composicion a base de aminoacidos para el tratamiento de infecciones.
Thacker et al. Parathyroid cyst of the mediastinum
RU2010151892A (ru) Способы снижения абсорбции липидов у животных
ES2710915T3 (es) Compuestos complejos de germanio, métodos para la producción de los mismos y fármacos
ES2217255T3 (es) Composiciones polipeptidicas farmaceuticas que contienen lisina y uso de las mismas.
ES2350039T3 (es) Compuestos inmunomoduladores que contienen gamma-glutamilo y beta-aspartilo y métodos con ellos.
ES2349233T3 (es) Preparación farmacéutica para su uso en el tratamiento o la profilaxis de enfermedades neoplásicas.
He et al. Effects of protein versus calcium supplementation on bone metabolism and development in fluoride-exposed offspring rats fed protein-and calcium-deficient diets
US20110105617A1 (en) Method for treatment of neoplastic diseases with alpha-keto glutarate and/or salts thereof